2,6-Dibromo-1H-purine(CAS: 1196-41-4)

2,6-Dibromo-1H-purine (CAS: 1196-41-4) is regulated under GHS (Globally Harmonized System of Classification and Labeling of Chemicals) with specific hazard categories. It is also subject to REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the European Union, requiring registration if produced or imported above a certain tonnage. FDA and EPA regulations may apply in the United States for its use in pharmaceuticals and pesticides.

Synthesis of 2,6-Dibromo-1H-purine can utilize alternative reagents such as bromine and its complexing agents. For instance, 2,6-dichloropurine can be brominated to form the target compound. Other purine derivatives like 6-bromopurine can also serve as starting materials in alternative synthetic routes.

The market for 2,6-Dibromo-1H-purine is primarily driven by its use in pharmaceuticals and research, particularly in nucleoside synthesis and antiviral drug development. Research trends include exploring its potential in drug discovery for treating viral infections and cancers. Market dynamics show increasing demand due to advancements in biotechnology and pharmaceutical research.

Waste containing 2,6-Dibromo-1H-purine should be collected in appropriate containers and incinerated in an industrial incinerator. Alternatively, professional waste disposal services should be used. Environmental precautions include ensuring containment to prevent spillage and proper ventilation during handling. Waste disposal should comply with local environmental regulations and chemical waste management guidelines.